Waters Corporation logo

Waters Corporation(WAT)

Leader

Waters Corporation (WAT) reported ~$2.97B revenue in FY2024. Premier maker of liquid chromatography instruments and mass spectrometers used in pharmaceutical quality control and research. HQ: Milford, MA.

Best for: Analytical InstrumentsMarket leader
80
AI Score
Grade A
AI Visibility Score (Beta)
HealthcareAnalytical InstrumentsWATWebsiteUpdated March 2026

Brand Intelligence Graphcompany

Integrates with
Capabilities
Analytical Instruments

Company Overview

About Waters Corporation

Waters Corporation is the global leader in analytical instruments and detection technologies for the life science, pharmaceutical, and materials science industries, best known for its high-performance liquid chromatography (HPLC) systems, ultra-high performance liquid chromatography (UPLC) platforms, and mass spectrometry instruments used in drug discovery, quality control, and regulatory compliance. Founded in 1958 by Jim Waters, the company pioneered the commercialization of HPLC technology that is now the standard method for separating and analyzing chemical mixtures in pharmaceutical manufacturing.

Business Model & Competitive Advantage

Waters reported approximately $2.97 billion in revenue in FY2024, with instruments (30–40% of revenue) complemented by a large and highly recurring chemistry consumables business (columns, reagents) and service/software. The consumables and services business — customers must continually purchase columns and reagents to run their instruments — creates a durable recurring revenue stream with near-100% retention. Waters' instruments are specified in FDA drug approval filings, creating switching costs as changing instruments requires revalidation.

Competitive Landscape 2025–2026

Waters' competitive position is anchored by the ACQUITY UPLC platform (introduced 2004), which remains the gold standard for pharmaceutical chromatography, and its industry-leading Xevo and Synapt mass spectrometers used for bioanalysis and structural proteomics. The company is well-positioned for biologics growth: monoclonal antibodies, gene therapies, and mRNA drugs require sophisticated analytical characterization that only high-resolution mass spectrometry can provide. Waters navigated a challenging 2023–2024 period as biopharma customers reduced capital spending, but underlying demand for its differentiated analytical platforms remains intact.

Founded
1958
Revenue
$2.97B
Curated content • Fact-checked and verified

Recent Activity

View all →

Key Differentiators

Market Leader

Waters Corporation is recognized as a market leader in the Healthcare Tech sector, demonstrating strong industry presence and customer trust.

Enterprise Scale

With $2.97B in revenue, Waters Corporation operates at enterprise scale with proven market validation.

Frequently Asked Questions

Estimated Visibility Trend (Beta)

Simulated 8-week rolling score

80
→ Stable

Based on estimated brand signals. Historical tracking coming soon.

Similar Brands

Idexx Laboratories logo

Idexx Laboratories

Healthcare Tech
B2bHealthtechManufacturingSaasPublic

IDEXX Laboratories is the global leader in veterinary diagnostics and information technology for companion animal healthcare, founded in 1983 by David Shaw in Westbrook, Maine, where it remains headqu

Revvity logo

Revvity

Healthcare Tech
B2bHealthtechManufacturingSaasPublic

Revvity, Inc. (formerly PerkinElmer) is a global life science tools and diagnostics company, rebranded in 2023 to signal its transformation from a diversified instruments company into a focused provid

GE HealthCare logo

GE HealthCare

Healthcare Tech
B2bHealthtechManufacturingSaasPublic

GE HealthCare Technologies Inc. is a Chicago, Illinois-based medical technology and digital health company — publicly traded on the NASDAQ (NASDAQ: GEHC) as an S&P 500 Health Care component — designin

Incyte logo

Incyte

Healthcare Tech
B2bHealthtechManufacturingSaasPublic

Incyte Corporation is a Wilmington, Delaware-based biopharmaceutical company — publicly traded on the NASDAQ (NASDAQ: INCY) as an S&P 500 Health Care component — focused on oncology and inflammation,

Biogen logo

Biogen

Healthcare Tech
B2bHealthtechManufacturingSaasPublic

Biogen Inc. is a Cambridge, Massachusetts-based neuroscience biopharmaceutical company — publicly traded on NASDAQ (NASDAQ: BIIB) as an S&P 500 Health Care component — researching, developing, and com

West Pharmaceutical Services logo

West Pharmaceutical Services

Healthcare Tech
B2bHealthtechManufacturingSaasPublic

West Pharmaceutical Services, Inc. is the global leader in packaging components and delivery systems for injectable medications, designing and manufacturing the stoppers, closures, caps, and drug deli

For Waters Corporation

Claim This Profile

Are you from Waters Corporation? Claim your profile to see full AI mention excerpts, get weekly visibility change alerts, and optimize how AI systems describe your brand.

Claim Waters Corporation Profile →
For competitors & analysts

Track AI Visibility in Real Time

Monitor how ChatGPT, Gemini, Perplexity, and Claude mention Waters Corporation vs competitors. Get alerts when AI recommendations shift.

Start Free Tracking →